| __timestamp | Apellis Pharmaceuticals, Inc. | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 3450000000 |
| Thursday, January 1, 2015 | 13730311 | 3560000000 |
| Friday, January 1, 2016 | 22978599 | 3628000000 |
| Sunday, January 1, 2017 | 40303878 | 4476000000 |
| Monday, January 1, 2018 | 105285576 | 3893000000 |
| Tuesday, January 1, 2019 | 220968770 | 4568000000 |
| Wednesday, January 1, 2020 | 299921000 | 5098000000 |
| Friday, January 1, 2021 | 420869000 | 5278000000 |
| Saturday, January 1, 2022 | 387236000 | 5488000000 |
| Sunday, January 1, 2023 | 354387000 | 6223000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, GSK plc and Apellis Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. GSK, a global healthcare giant, consistently allocated substantial funds, with a peak of approximately $6.2 billion in 2023, marking a 44% increase from 2014. In contrast, Apellis, a burgeoning biotech firm, showcased a remarkable growth trajectory, with R&D expenses surging by over 4,100% from 2014 to 2021, peaking at around $421 million. This stark difference highlights GSK's steady commitment to maintaining its market position, while Apellis's aggressive investment strategy underscores its ambition to innovate and expand. As the pharmaceutical landscape continues to shift, these R&D strategies will play a pivotal role in shaping the future of healthcare.
R&D Spending Showdown: Merck & Co., Inc. vs GSK plc
GSK plc or Biogen Inc.: Who Invests More in Innovation?
Research and Development Investment: GSK plc vs Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: GSK plc vs Vericel Corporation
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.